Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
sodium hyaluronate (Ordain Health Care)
- Development stage
- Unknown
- Lead developer
- Ordain Health Care
- Modality
- Small Molecules
- Administration
- Ophthalmic
01
Overview
Hymelon is an ophthalmic formulation of sodium hyaluronate (0.18% w/v) developed and marketed by Ordain Health Care (a subsidiary of Exeltis). Sodium hyaluronate is the sodium salt of hyaluronic acid, a naturally occurring glycosaminoglycan with high viscoelastic and water-retaining properties. Administered as eye drops, Hymelon acts as an artificial tear to lubricate, moisten, and protect the ocular surface. It is primarily indicated for the relief of dryness, soreness, irritation, and discomfort associated with dry eye syndrome, as well as for promoting corneal healing after minor eye injuries such as corneal abrasions.
- Brand names
- HymelonHymelon Max
- Other names
- hyaluronanhyaluronan sodiumhyaluronic acidhyaluronic acid sodium salt
02
Targets
CD44 (CD44 antigen)ICAM1 (Intercellular Adhesion Molecule 1)LAYN (Layilin)HMMRSTAB2 (Stabilin-2)TLR2 (Toll-like Receptor 2)TLR4 (Toll-like receptor 4)
Beyond the preview
Go deeper on sodium hyaluronate (Ordain Health Care).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on sodium hyaluronate (Ordain Health Care).